Form 4 for TVTX Travere Therapeutics, Inc.
Accepted 2026-05-21 17:00:10 ET · period of report 2026-05-19 · accession 0001376043-26-000006 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-05-21 17:00 | 2026-05-19 | TVTX | Coughlin Timothy | Dir | A - Grant | $0.00 | +4,000 | 56.2K | +8% | $0 |
| D | 2026-05-21 17:00 | 2026-05-19 | TVTX | Coughlin Timothy | Dir | A - Grant | $0.00 | +12.0K | 12.0K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-05-19 | A | A | 4,000 | $0.00 | 56,250 | D | — | — | (F1) Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program. (F2) The equity award vests over a one year period. |
| 2 | Derivative | Stock option (right to buy) | 2026-05-19 | A | A | 12,000 | $0.00 | 12,000 | D | $42.26 · 2027-05-19 to 2036-05-19 | 12,000 Common Stock | (F1) Automatic equity grant under the Issuer's 2018 Equity Incentive Plan, as amended, pursuant to the non-employee director compensation program. (F2) The equity award vests over a one year period. |